Rocket


News + Filings
Transactions





Higgons John Duncan

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/24/2022Jounce Therapeutics, Inc.JNCEGrantStock Option (Right to Buy)20k$2.80$56k 06/24/2022
06/18/2021Jounce Therapeutics, Inc.JNCEGrantStock Option (Right to Buy)15.7k$7.27$114.1k 06/18/2021
04/15/2021Jounce Therapeutics, Inc.JNCESaleCommon Stock200$10.00$2k 04/15/2021
03/15/2021Jounce Therapeutics, Inc.JNCESaleCommon Stock200$12.80$2.6k 03/15/2021
02/16/2021Jounce Therapeutics, Inc.JNCESaleCommon Stock200$11.78$2.4k 02/16/2021
01/21/2021Jounce Therapeutics, Inc.JNCESaleCommon Stock200$11.11$2.2k 01/20/2021
01/20/2021Jounce Therapeutics, Inc.JNCESaleCommon Stock1.5k$12.00$18k 01/20/2021
06/26/2020Jounce Therapeutics, Inc.JNCEGrantStock Option (Right to Buy)15.7k$7.58$119k 06/26/2020
06/26/2020Jounce Therapeutics, Inc.JNCEGrantStock Option (Right to Buy)13.6k$7.58$102.7k 06/26/2020
01/06/2020Jounce Therapeutics, Inc.JNCESaleCommon Stock1.5k$8.11$12.2k 01/06/2020
06/12/2019Jounce Therapeutics, Inc.JNCEGrantStock Option (Right to Buy)15.7k$4.46$70k 06/12/2019
06/19/2018Jounce Therapeutics, Inc.JNCEGrantStock Option (Right to Buy)13.6k$7.92$107.3k 06/19/2018
02/01/2017Jounce Therapeutics, Inc.JNCEPurchaseCommon Stock6.7k$16.00$107.2k 02/01/2017

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy